Sa. Charman et al., Lymphatic absorption is a significant contributor to the subcutaneous bioavailability of insulin in a sheep model, PHARM RES, 18(11), 2001, pp. 1620-1626
Purpose. This study was conducted to explore the role of the peripheral lym
phatics in insulin absorption following subcutaneous (SC) administration us
ing a sheep model that allows continuous collection of peripheral lymph and
simultaneous assessment of systemic bioavailability.
Methods: In a parallel group design, soluble human insulin (0.5 IU/ kg) was
administered by bolus SC injection into the interdigital space of the hind
leg of non-cannulated control sheep, and sheep in which the efferent popli
teal lymph duct was cannulated. A separate group received a bolus IV inject
ion (0.15 IU/kg). Blood was sampled from all animals, and lymph was collect
ed continuously over 12 h postdosing. Samples were assayed for insulin by E
LISA.
Results. The SC bioavailability of insulin in control sheep was 31.5 +/- 3.
2%, which was significantly higher than when the peripheral lymph was conti
nuously collected (18.4 +/- 1.7%). In the lymph-cannulated animals, 17.3 +/
- 1.0% of the dose was collected in peripheral lymph. Conclusions. Based on
the direct measurement of insulin in regional lymph and on the decrease in
the systemic bioavailability when rea gional lymph was continuously collec
ted, the results demonstrate that lymphatic absorption contributed signific
antly to the overall insulin bioavailability following SC administration to
sheep.